Trial Outcomes & Findings for Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope (NCT NCT03298841)
NCT ID: NCT03298841
Last Updated: 2021-04-22
Results Overview
operating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center
COMPLETED
50 participants
during surgery assessed up to one hour
2021-04-22
Participant Flow
Participant milestones
| Measure |
Zeiss Group
patients undergoing uncomplicated phacoemulsification using Zeiss Lumera microscope with Callisto software
|
Leica Stativ S3B
patients undergoing uncomplicated phacoemulsification using Leica Stativ S3B microscope
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Zeiss Group
n=25 Participants
patients undergoing uncomplicated phacoemulsification using Zeiss Lumera microscope with Callisto software
|
Leica Stativ S3B
n=25 Participants
patients undergoing uncomplicated phacoemulsification using Leica Stativ S3B microscope
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=25 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=50 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
22 Participants
n=25 Participants
|
23 Participants
n=25 Participants
|
45 Participants
n=50 Participants
|
|
Age, Categorical
>=65 years
|
3 Participants
n=25 Participants
|
2 Participants
n=25 Participants
|
5 Participants
n=50 Participants
|
|
Sex: Female, Male
Female
|
15 Participants
n=25 Participants
|
16 Participants
n=25 Participants
|
31 Participants
n=50 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=25 Participants
|
9 Participants
n=25 Participants
|
19 Participants
n=50 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
25 participants
n=25 Participants
|
25 participants
n=25 Participants
|
50 participants
n=50 Participants
|
PRIMARY outcome
Timeframe: during surgery assessed up to one hourPopulation: patients undergoing uncomplicated phacoemulsification by two surgeons at one surgery site
operating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center
Outcome measures
| Measure |
Zeiss Group
n=25 Participants
patients undergoing uncomplicated phacoemulsification using Zeiss Lumera microscope with Callisto software
|
Leica Stativ S3B
n=25 Participants
patients undergoing uncomplicated phacoemulsification using Leica Stativ S3B microscope
|
|---|---|---|
|
Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope
|
11.15 minutes per surgical procedure
Standard Deviation 2.42
|
14.18 minutes per surgical procedure
Standard Deviation 8.67
|
SECONDARY outcome
Timeframe: 6 weeksPopulation: patients scheduled for routine cataract surgery with one of two experienced surgeons
events that are life or vision threatening, that require hospitalization or permanent disability of any type
Outcome measures
| Measure |
Zeiss Group
n=50 Participants
patients undergoing uncomplicated phacoemulsification using Zeiss Lumera microscope with Callisto software
|
Leica Stativ S3B
patients undergoing uncomplicated phacoemulsification using Leica Stativ S3B microscope
|
|---|---|---|
|
Number of Serious Adverse Events During Intra-operative and Post-operative Period
|
0 Participants
|
—
|
Adverse Events
Zeiss Group
Leica Stativ S3B
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place